Bharat Rasayan Ltd

Bharat Rasayan Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Bharat Rasayan Ltd

₹ 11,261 0.33%
22 Nov 11:00 a.m.
bharatgroup.co.in BSE: 590021 NSE: BHARATRAS
About

Bharat Rasayan Ltd is engaged in manufacturing Technical Grade Pesticides and Intermediates used in the agro-chemical industry. It was incorporated in 1989.[1]

Key Points

Product Portfolio
The company has a leading market position in many technical and intermediate products, including Lambda Cyhalothrin Technical, Metaphenoxy Benzaldehyde, Metribuzine Technical, Thiamethoxam (Insecticides), Fipronil (Insecticides), etc. It has also added new products like Fluxametamide, Tolfenpyrad Technical, Diuron Technical, etc. Top 10 products account for 66% of total sales. [1]

Website BSE NSE
  • Market Cap ₹ 4,679 Cr.
  • Current Price ₹ 11,261
  • High / Low ₹ 14,284 / 8,333
  • Stock P/E 29.7
  • Book Value ₹ 2,561
  • Dividend Yield 0.01 %
  • ROCE 12.6 %
  • ROE 10.0 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • The company has delivered a poor sales growth of 1.08% over past five years.
  • Dividend payout has been low at 0.50% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
269 335 445 327 292 309 306 239 263 233 310 282 328
229 265 359 276 256 260 249 234 250 207 240 244 281
Operating Profit 40 70 86 51 36 49 56 6 13 26 69 38 47
OPM % 15% 21% 19% 16% 12% 16% 18% 2% 5% 11% 22% 14% 14%
3 -0 7 8 3 6 -3 9 4 4 22 22 7
Interest 1 2 3 2 1 2 1 0 1 1 1 1 1
Depreciation 6 7 7 6 7 7 6 6 6 7 6 6 6
Profit before tax 36 61 83 51 31 46 46 8 10 22 84 53 46
Tax % 26% 25% 23% 26% 26% 27% 34% 8% 39% 29% 20% 19% 30%
26 46 65 38 23 34 30 7 6 15 67 43 32
EPS in Rs 63.70 110.41 155.34 90.63 55.18 81.27 72.80 17.06 14.44 36.84 161.50 103.77 77.35
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
989 1,213 1,091 1,301 1,234 1,044 1,153
802 983 852 1,050 1,043 926 972
Operating Profit 188 230 240 250 191 118 180
OPM % 19% 19% 22% 19% 15% 11% 16%
1 14 6 16 15 35 55
Interest 16 16 4 7 6 3 5
Depreciation 17 22 26 25 26 26 26
Profit before tax 155 205 215 234 174 123 205
Tax % 28% 23% 24% 25% 28% 23%
112 158 164 176 125 96 158
EPS in Rs 262.48 371.03 385.69 423.51 299.88 229.85 379.46
Dividend Payout % 1% 0% 0% 0% 0% 1%
Compounded Sales Growth
10 Years: %
5 Years: 1%
3 Years: -1%
TTM: 3%
Compounded Profit Growth
10 Years: %
5 Years: -4%
3 Years: -17%
TTM: 97%
Stock Price CAGR
10 Years: 28%
5 Years: 13%
3 Years: 4%
1 Year: 23%
Return on Equity
10 Years: %
5 Years: 20%
3 Years: 16%
Last Year: 10%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 4 4 4 4 4 4 4
Reserves 405 560 723 766 889 984 1,060
247 94 58 174 28 80 63
100 94 122 142 152 129 167
Total Liabilities 756 752 908 1,086 1,074 1,197 1,294
150 203 191 228 225 230 235
CWIP 35 18 18 11 11 6 14
Investments 0 9 150 43 67 143 186
570 522 549 803 771 818 859
Total Assets 756 752 908 1,086 1,074 1,197 1,294

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
-52 263 170 -65 213 41
-46 -53 -149 64 -43 -76
102 -169 -40 -25 -152 49
Net Cash Flow 4 40 -19 -26 18 14

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 103 75 99 130 96 138
Inventory Days 112 70 90 120 141 135
Days Payable 24 17 33 30 33 37
Cash Conversion Cycle 191 128 156 221 204 236
Working Capital Days 173 116 134 185 173 227
ROCE % 34% 31% 28% 20% 13%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
75.05% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99%
0.00% 0.00% 0.00% 0.53% 0.39% 0.34% 0.35% 0.35% 0.34% 0.34% 0.35% 0.46%
2.28% 2.84% 2.89% 2.57% 2.60% 2.57% 2.57% 2.57% 2.57% 2.57% 2.59% 2.64%
22.67% 22.17% 22.11% 21.91% 22.02% 22.10% 22.09% 22.09% 22.09% 22.09% 22.07% 21.90%
No. of Shareholders 19,31716,74717,38416,37517,30417,23416,36116,05915,39814,66715,15615,889

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings